Article
Gli2 Overexpression Alters the Differentiation Status of Dedifferentiated Liposarcoma…
medRxiv · 2024 · Bennett, N. E.; Beadle, E. P.; Parker, D. V.; Coe, E. J.; Cottam, M. A.; Baum, J. E.; Miller, J. S.; Serrenho, J. A.; Rhoades, J. A.
Key facts
| Title | Gli2 Overexpression Alters the Differentiation Status of Dedifferentiated Liposarcoma Cells and Results in an Immunosuppressive Myeloid Phenotype in Orthotopic Tumors |
|---|---|
| First author | Bennett, N. E.; Beadle, E. P.; Parker, D. V.; Coe, E. J.; Cottam, M. A.; Baum, J. E.; Miller, J. S.; Serrenho, J. A.; Rhoades, J. A. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.09.18.613793 |
| Devices mentioned | K800781, K802418 |
| Product codes mentioned | KIS, MVU, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1